Seòmar agus comataidhean

Detailed workforce planning, in partnership with NHS Scotland health boards is underway to enable delivery of the next stage of COVID-19 vaccinations, alongside the seasonal influenza vaccination programme. On 05 July 2021, we provided health boards with the latest available planning assumptions and advice from the Joint Committee on Vaccination and Immunisation. This included workforce deployment requirements, broken down by health board, alongside planning information to enable health boards to continue to work towards building a sustainable vaccinations workforce. We will share further workforce planning information with MSPs shortly on the plans for the delivery of Covid-19 and seasonal influenza vaccinations across NHS Scotland this coming autumn.

The Scottish Government is able to provide details of contracts awarded by itself to third sector organisations however, without disproportionate time, cost and extensive review of many thousands of individual contractual agreements we are unable to provide data for other Public Bodies.

The data provided has been taken from Public Contracts Scotland (PCS), the Scottish Government's advertising portal. The data provided start from 2010 (when PCS was established), and are reliant on suppliers self-selecting their third sector status.

Details of contracts-frameworks awarded by the Scottish Government to third sector organisations are contained in the following table:

The information requested is publically available from PHS. This release provides information on alcohol-related inpatient and day case activity within general acute and psychiatric hospitals in Scotland. The release covers general acute hospital activity for the financial years 1981 to 1982, until 2019 to 2020 and psychiatric hospital admissions from 1997 to 1998 until 2018 to 2019. Due to limited data completeness the psychiatric hospital admissions were not updated for the financial year 2019 to 2020.

The most recent publication is available here Alcohol related hospital statistics - Scotland financial year 2019 to 2020 - Alcohol related hospital statistics - Publications - Public Health Scotland.

More detailed information on alcohol treatment will become available for future years following the full implementation of the DAISy system which went live from 1 December 2020.

The Animal Welfare (Licensing of Activities Involving Animals) (Scotland) Regulations 2021 were approved by the Scottish Parliament on 10 February 2021 and will come into force on 1 September 2021. These regulations are concerned with modernising the licensing of dog, cat and rabbit breeding activities, pet selling - including the trade in young dogs, the operation of animal sanctuaries and animal rehoming activities.

Additionally, the Scottish Government works closely with a number of animal welfare organisations, other UK Government departments, the veterinary sector and enforcement agencies on the Puppy Trade Working Group to disrupt the activities of unlicensed and/or low welfare breeders and educate the public about how best to buy a puppy safely.

Local authorities are independent corporate bodies with their own powers and responsibilities, separate from the Scottish Government. As such, the information requested is not held by the Scottish Government and would have to be obtained directly from individual local authorities or from COSLA.

In October 2019 the Scottish Health Technology Group (SHTG) recommended that: “Where patients understand and are willing to accept the demands, risks and uncertainties of treatment, autologous haematopoietic stem cell transplant (AHSCT) should be considered as a treatment option for patients with relapsing-remitting multiple sclerosis (RRMS) who have evidence of significant inflammatory disease activity that has not responded to adequate treatment with licensed high-efficacy disease modifying therapies (DMTs).”

Following comprehensive clinical assessment, relevant diagnostic testing and consideration by a specialist multi-disciplinary team, AHSCT can be offered to MS patients from Scotland where they meet this criteria and when it is clinically judged that the benefits of treatment outweigh the risks. In these circumstances such patients can be referred by their NHS Consultant for this specific treatment at a specialist centre in England.

Stem cell transplantation is currently undertaken in Scotland for other clinical reasons, however specific expertise in its use for the treatment of MS is still developing. In order to ensure that patients receive the highest level of safe, patient-centred care, clinical consensus is that this is currently best delivered by one of the most experienced centres globally, located in Sheffield. Although delayed by the need to focus resources on COVID-19, key stakeholders within NHS Scotland are continuing discussions regarding a potential Scottish pathway for this treatment.

AHSCT is an intensive treatment which carries a very high risk of infection for many weeks, due to severe immunosuppression as part of the treatment pathway. In March 2020 the Association of British Neurologists (ABN) recommended postponing this treatment in patients with MS until the risk of coronavirus receded, due to the potential for severe illness in those with compromised immune systems. As of November 2020, the ABN advises its use only in exceptional cases of relapsing disease.

While the Scottish Government has overall responsibility for health and social care policy in Scotland, it is for the regional health & social care partnerships to determine the level of services that are required to meet local needs and to arrange an appropriate and suitable range of services to meet these local needs, as mandated under statute in the Public Bodies (Joint Working) (Scotland) Act.

Local Authorities are distinct corporate bodies whose powers are set out in statute and as such are entirely separate from the Scottish Government, however it is the expectation of the Scottish Government that Local Public Bodies will engage with autistic people and children, including their families where appropriate, in relation to decisions regarding the allocation of funding for autism services.

In addition, the Scottish Government works closely with COSLA and HSCPs in relation to the aims and objectives of our national autism strategies. Those strategies and the delivery of them is shared jointly between the Scottish Government and COSLA. We are currently looking at monitoring and engagement arrangements for the “Towards Transformation” plan involving a range of key stakeholders, including people with learning disabilities and autistic people.

While the Scottish Government has overall responsibility for health and social care policy in Scotland, it is for the regional health & social care partnerships to determine the level of services that are required to meet local needs and to arrange an appropriate and suitable range of services to meet these local needs, as mandated under statute in the Public Bodies (Joint Working) (Scotland) Act.

Local Authorities are distinct corporate bodies whose powers are set out in statute and as such are entirely separate from the Scottish Government, however it is the expectation of the Scottish Government that Local Public Bodies will operate their own autism strategies which will involve engaging with Autistic people in relation to decisions that affect them in an accessible way.

a) This is not monitored nationally.

b) This is a matter for local public bodies. The information requested is not held centrally.

The Scottish Government recognises the severe impact the Covid-19 pandemic has had on performing arts and venues, with the necessary restrictions meaning that many activities have had to be suspended. The effects of these restrictions on the performing arts sector has been considered in the various Business and Regulatory Impact Assessments (BRIA) in relation to the impact of the pandemic. These BRIAs have been informed by engagement with relevant businesses.

The latest BRIA , agreed by Ministers on 24 June, considered the available evidence and presented reasonable views of likely costs, benefits and impacts of the measures set out in the regulations and guidance. It was recognised that the limitations on performing arts venues are part of an overall system to balance suppression of the virus while minimising wider harm to Scotland’s health and wellbeing, as well as minimising the wider social and economic harms associated with the measures.

The Scottish Government has recently provided an additional £25 million to businesses in the culture sector, via a second round of the Culture Organisations and Venues Recovery Fund and the Performing Arts Venues Relief Fund, to help mitigate the impact of these necessary restrictions.

Requirements for entering Scotland are currently aligned on a Four Nations basis and differ depending on whether the individual arrives from a red, amber or green listed country.

All arrivals are required to provide a negative Covid-19 test in the three days prior to travel, they are then required to undertake the following actions:

• Red – studying in the UK is currently one of the allowable reasons for entering Scotland from a red-list country. International students over 18 years old arriving from a country on this list, or who have been in a red list country in the 10 days prior, are required to enter managed quarantine for 10 days.
• Amber – International students arriving from amber-list countries, or who have been in an Amber list country in the 10 days prior, are required to isolate in their place of residence for 10 days, additionally they are required to take a Covid-19 test on or before day 2 and on or after day 8 of their 10 day isolation.
• Green – International students arriving from green-list countries are not required to isolate unless the result of a COVID-19 test taken on day 2 after arriving back in Scotland is positive.